Trial intelligence / Profile preview

Suvorexant for Insomnia in Older Adults

NCT05908526Phase 2Completed

Sponsor
University of Maryland, Baltimore
Start
Oct 2023
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of suvorexant in Insomnia, sponsored by University of Maryland, Baltimore. Started Oct 2023; status: completed.

02

Drugs

suvorexant
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT05908526.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05908526.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call